CanBas Co.,Ltd. — Investor Relations & Filings
CanBas is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on drug discovery in the field of oncology, including immuno-oncology and treatments targeting the cell cycle. Its pipeline includes CBP501, a calmodulin-modulating peptide that has undergone Phase II clinical trials. CanBas leverages proprietary screening systems and core technologies to develop innovative anti-cancer agents, with a focus on creating treatments with potentially fewer side effects.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 確認書 | 2025-09-29 | Japanese | |
| 有価証券報告書-第26期(2024/07/01-2025/06/30) | 2025-09-29 | Japanese | |
| 確認書 | 2025-02-13 | Japanese | |
| 半期報告書-第26期(2024/07/01-2025/06/30) | 2025-02-13 | Japanese | |
| 臨時報告書 | 2024-09-30 | Japanese | |
| 内部統制報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
4 filings
| |||||
| 7936822 | 確認書 | 2025-09-29 | Japanese | ||
| 7936821 | 有価証券報告書-第26期(2024/07/01-2025/06/30) | 2025-09-29 | Japanese | ||
| 7277568 | 確認書 | 2025-02-13 | Japanese | ||
| 7277570 | 半期報告書-第26期(2024/07/01-2025/06/30) | 2025-02-13 | Japanese | ||
|
2024
8 filings
| |||||
| 7306965 | 臨時報告書 | 2024-09-30 | Japanese | ||
| 7307431 | 内部統制報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese | ||
| 7307422 | 確認書 | 2024-09-27 | Japanese | ||
| 7307425 | 有価証券報告書-第25期(2023/07/01-2024/06/30) | 2024-09-27 | Japanese | ||
| 7339431 | 確認書 | 2024-05-10 | Japanese | ||
| 7339419 | 四半期報告書-第25期第3四半期(2024/01/01-2024/03/31) | 2024-05-10 | Japanese | ||
| 7357384 | 確認書 | 2024-02-09 | Japanese | ||
| 7357385 | 四半期報告書-第25期第2四半期(2023/10/01-2023/12/31) | 2024-02-09 | Japanese | ||
|
2023
3 filings
| |||||
| 7539934 | 確認書 | 2023-11-10 | Japanese | ||
| 7539886 | 四半期報告書-第25期第1四半期(2023/07/01-2023/09/30) | 2023-11-10 | Japanese | ||
| 7544102 | 臨時報告書 | 2023-09-27 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
CanBas Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/13588/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=13588 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=13588 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=13588 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 13588}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CanBas Co.,Ltd. (id: 13588)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.